Securities Class Action

In Litigation

1

Settlement

0

Closed

0

Total Settlement

$0

Material Events

Critical Governance & Disclosure

7

Board, Voting & Shareholder Rights

7

Capital Structure & Financial Risk

2

Disclosure & Communications

10

SEC Filings

8-K

Current report

2026-11-12

View 8-K Current report on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-11-12

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
PRER14A

Preliminary Proxy Soliciting materials

2026-10-28

View PRER14A Preliminary Proxy Soliciting materials on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-09-24

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-09-24

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov

Insider Transaction

No Insider Transactions found for Skye Bioscience, Inc.